Earnings Surprise
Search documents
Arcellx, Inc. (ACLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
ZACKS· 2025-10-30 15:07
Core Insights - Arcellx, Inc. (ACLX) is anticipated to report a year-over-year decline in earnings due to lower revenues for the quarter ended September 2025, with a consensus EPS estimate of a loss of $0.96 per share, reflecting a -100% change [1][3] - Revenues are projected to be $14.64 million, down 43.8% from the same quarter last year [3] - The consensus EPS estimate has been revised 12.39% higher in the last 30 days, indicating a reassessment by analysts [4] Earnings Expectations - The upcoming earnings report could lead to a stock price increase if results exceed expectations, while a miss could result in a decline [2] - The Earnings Whisper model suggests that revisions prior to earnings releases provide insights into business conditions [7] Earnings Surprise Prediction - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, with a positive Earnings ESP indicating a likely earnings beat [8][9] - For Arcellx, the Most Accurate Estimate is higher than the consensus, resulting in an Earnings ESP of +7.60%, suggesting a strong likelihood of beating the consensus EPS estimate [12] Historical Performance - In the last reported quarter, Arcellx was expected to post a loss of $1.03 per share but actually reported a loss of -$0.94, achieving a surprise of +8.74% [13] - Over the past four quarters, Arcellx has beaten consensus EPS estimates two times [14] Industry Context - Another company in the biomedical sector, Geron (GERN), is expected to report a loss of $0.03 per share, indicating a year-over-year change of +25%, with revenues projected at $52.49 million, up 85.7% [18] - Geron's consensus EPS estimate has been revised 7.7% lower, resulting in an Earnings ESP of -32.35%, combined with a Zacks Rank of 4 (Sell), making it challenging to predict an earnings beat [19][20]
MP Materials Corp. (MP) Expected to Beat Earnings Estimates: Should You Buy?
ZACKS· 2025-10-30 15:01
Core Viewpoint - Wall Street anticipates a year-over-year decline in earnings for MP Materials Corp. due to lower revenues, with a focus on how actual results compare to estimates impacting stock price [1][2]. Company Summary - The upcoming earnings report for MP Materials is expected to show a quarterly loss of $0.14 per share, reflecting a year-over-year change of -16.7% [3]. - Revenues are projected to be $53.14 million, down 15.6% from the same quarter last year [3]. - The consensus EPS estimate has been revised 13.04% higher in the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for MP Materials is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +8.77%, suggesting a likelihood of beating the consensus EPS estimate [12]. Earnings Surprise History - In the last reported quarter, MP Materials was expected to post a loss of $0.17 per share but actually reported a loss of -$0.13, resulting in a positive surprise of +23.53% [13]. - Over the last four quarters, the company has only beaten consensus EPS estimates once [14]. Industry Context - In the Zacks Mining - Miscellaneous industry, Ur Energy is expected to post a loss of $0.03 per share, indicating a year-over-year change of -50% [18]. - Ur Energy's revenue is expected to be $6.83 million, up 6.7% from the previous year [18]. - The consensus EPS estimate for Ur Energy has been revised 33.3% lower in the last 30 days, resulting in an Earnings ESP of -12.50%, making it difficult to predict a beat on the consensus EPS estimate [19].
Fox Corporation (FOX) Q1 Earnings and Revenues Top Estimates
ZACKS· 2025-10-30 13:46
Core Insights - Fox Corporation reported quarterly earnings of $1.51 per share, exceeding the Zacks Consensus Estimate of $1.06 per share, and showing an increase from $1.45 per share a year ago, resulting in an earnings surprise of +42.45% [1] - The company achieved revenues of $3.74 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 4.66% and up from $3.56 billion year-over-year [2] - Fox shares have increased approximately 18.8% year-to-date, outperforming the S&P 500's gain of 17.2% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.74 on revenues of $4.92 billion, and for the current fiscal year, it is $4.14 on revenues of $15.71 billion [7] - The estimate revisions trend for Fox was favorable ahead of the earnings release, resulting in a Zacks Rank 1 (Strong Buy) for the stock, indicating expected outperformance in the near future [6] Industry Context - The Broadcast Radio and Television industry, to which Fox belongs, is currently ranked in the bottom 41% of over 250 Zacks industries, suggesting that the industry's outlook can significantly impact stock performance [8]
Is Kinross Gold Stock a Smart Buy Before Q3 Earnings Release?
ZACKS· 2025-10-30 13:01
Core Insights - Kinross Gold Corporation (KGC) is expected to report third-quarter 2025 results on Nov. 4, with anticipated benefits from higher gold prices, effective cost management, and strong production [1][6][19] Financial Performance - The Zacks Consensus Estimate for third-quarter earnings is 33 cents per share, reflecting a 37.5% year-over-year increase, while revenue is estimated at $1.53 billion, indicating a 6.9% rise year-over-year [2] - KGC has outperformed the Zacks Consensus Estimate for earnings in three of the last four quarters, with an average earnings surprise of 22.5% [3][4] Market Conditions - Gold prices have significantly increased due to global trade tensions, geopolitical issues, a weak dollar, and central bank purchases, with prices closing nearly 17% higher in the third quarter and approximately 52% higher year-to-date [8][6] - The average realized gold price per ounce for KGC in the third quarter is estimated at $3,230, representing a 30.4% increase from the previous year [8] Production and Cost Management - KGC's strong production profile is supported by key assets Tasiast and Paracatu, which are expected to contribute significantly to cash flow and production [9][10] - The company's cost-control measures, combined with robust gold prices, are anticipated to maintain strong margin performance in the third quarter [10] Stock Performance and Valuation - KGC's shares have increased by 129.2% over the past year, outperforming the Zacks Mining – Gold industry's 71.1% rise and the S&P 500's 23% increase [11] - Kinross Gold is currently trading at a forward 12-month earnings multiple of 13.45, slightly above the peer group average of 13.08 [14] Investment Outlook - KGC has a strong pipeline of exploration and development projects, including Great Bear in Ontario and Round Mountain Phase X in Nevada, which are expected to enhance production and cash flow [17] - The company demonstrates strong financial health, with substantial cash flows that support development projects and shareholder returns [18][19]
Eli Lilly (LLY) Q3 Earnings and Revenues Surpass Estimates
ZACKS· 2025-10-30 12:55
Core Insights - Eli Lilly (LLY) reported quarterly earnings of $7.02 per share, exceeding the Zacks Consensus Estimate of $6.02 per share, and significantly up from $1.18 per share a year ago, representing an earnings surprise of +16.61% [1][2] - The company achieved revenues of $17.6 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 9.91%, compared to $11.44 billion in the same quarter last year [2] - Lilly has outperformed consensus EPS estimates three times over the last four quarters and has topped revenue estimates four times in the same period [2] Earnings Outlook - The sustainability of the stock's price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - Current consensus EPS estimate for the upcoming quarter is $7.05 on revenues of $17.44 billion, while for the current fiscal year, the estimate is $22.73 on revenues of $61.77 billion [7] Market Performance - Lilly shares have increased approximately 5.4% since the beginning of the year, underperforming the S&P 500, which has gained 17.2% [3] - The estimate revisions trend for Lilly was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Large Cap Pharmaceuticals industry, to which Lilly belongs, is currently in the bottom 25% of the Zacks industry rankings, which may negatively impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that investors should monitor these revisions closely [5]
CMS Energy (CMS) Q3 Earnings and Revenues Surpass Estimates
ZACKS· 2025-10-30 12:40
Core Insights - CMS Energy reported quarterly earnings of $0.93 per share, exceeding the Zacks Consensus Estimate of $0.86 per share, and showing an increase from $0.84 per share a year ago, resulting in an earnings surprise of +8.14% [1] - The company generated revenues of $2.02 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 11.17%, compared to $1.74 billion in the same quarter last year [2] - CMS Energy has outperformed consensus EPS estimates three times in the last four quarters and has also topped revenue estimates three times during the same period [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.00 on revenues of $2.12 billion, while for the current fiscal year, the estimate is $3.59 on revenues of $8.38 billion [7] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Utility - Electric Power industry, to which CMS Energy belongs, is currently ranked in the top 24% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]
Pacific Gas & Electric Stock: Is Wall Street Bullish or Bearish?
Yahoo Finance· 2025-10-30 10:30
Core Viewpoint - Pacific Gas & Electric Company (PCG) is facing significant stock underperformance compared to the broader market and utility sector, despite reporting better-than-expected earnings for Q3 FY2025 and unveiling a substantial capital plan for future growth [2][4][5]. Financial Performance - PCG's stock has declined by 21.7% over the past 52 weeks, while the S&P 500 Index has gained 18.1% during the same period [2]. - Year-to-date, PCG's stock has slid 21.9%, contrasting with the S&P 500's 17.2% gain [2]. - The company's adjusted EPS for Q3 FY2025 was $0.50, exceeding expectations of $0.42, driven by stronger demand and lower operating expenses [4]. - Revenue for the quarter was $6.25 billion, slightly below estimates [4]. - Analysts expect PCG's EPS to grow 10.3% annually to $1.50 for the fiscal year ending December 2025 [5]. Analyst Ratings and Price Targets - Among 18 analysts covering PCG, the consensus rating is a "Moderate Buy," with 12 "Strong Buy" ratings and six "Holds" [5]. - The mean price target for PCG is $21.07, indicating a potential upside of 33.7% from current market prices [6]. - The highest price target of $25 suggests a potential upside of 58.6% [6].
Compared to Estimates, Wex (WEX) Q3 Earnings: A Look at Key Metrics
ZACKS· 2025-10-30 00:01
Core Insights - Wex reported revenue of $691.8 million for the quarter ended September 2025, reflecting a 4% increase year-over-year and a surprise of +1.44% over the Zacks Consensus Estimate [1] - Earnings per share (EPS) for the quarter was $4.59, up from $4.35 in the same quarter last year, with an EPS surprise of +3.15% compared to the consensus estimate of $4.45 [1] Financial Performance Metrics - Average US fuel price was $3.38 per gallon, exceeding the average estimate of $3.26 per gallon [4] - Corporate Payments purchase volume was reported at $23.18 billion, slightly below the average estimate of $23.53 billion [4] - Benefits purchase volume reached $1.77 billion, compared to the average estimate of $1.85 billion [4] - Mobility payment processing transactions totaled 140 million, compared to the average estimate of 142.98 million [4] - Mobility revenues were $360.8 million, surpassing the average estimate of $350.31 million, marking a +1% year-over-year change [4] - Corporate Payments revenues were $132.8 million, below the average estimate of $144.49 million, with a +4.7% year-over-year change [4] - Benefits revenues were $198.1 million, exceeding the average estimate of $185.18 million, reflecting a +9.2% year-over-year change [4] - Corporate Payments payment processing revenues were $109.7 million, slightly above the average estimate of $109.02 million, with a +4.7% year-over-year change [4] - Benefits payment processing revenues were $23.8 million, below the average estimate of $25.06 million, with an +8.7% year-over-year change [4] - Benefits account servicing revenues were $113.3 million, close to the average estimate of $113.54 million, reflecting a +3% year-over-year change [4] - Benefits other revenues were $61 million, exceeding the average estimate of $57.99 million, with a +23.5% year-over-year change [4] - Mobility payment processing revenues were $168.2 million, below the average estimate of $172.04 million, reflecting an -8.2% year-over-year change [4] Stock Performance - Wex shares returned +0.8% over the past month, compared to the Zacks S&P 500 composite's +3.8% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]
Will Eos Energy Enterprises, Inc. (EOSE) Report Negative Earnings Next Week? What You Should Know
ZACKS· 2025-10-29 15:10
Core Insights - Eos Energy Enterprises, Inc. (EOSE) is expected to report a year-over-year increase in earnings driven by higher revenues for the quarter ended September 2025, with a consensus estimate of a loss of $0.29 per share, reflecting a 34.1% improvement from the previous year [1][3] - Revenues are projected to reach $39.81 million, representing a significant increase of 4583.5% compared to the same quarter last year [3] - The earnings report is anticipated to be released on November 5, and the actual results will be crucial in determining the stock's near-term price movement [2] Estimate Revisions Trend - The consensus EPS estimate has been revised 6.86% higher in the last 30 days, indicating a collective reassessment by analysts [4] - Despite the upward revision, the Most Accurate Estimate for Eos Energy is lower than the Zacks Consensus Estimate, leading to an Earnings ESP of -53.85%, suggesting a bearish outlook from analysts [12] Earnings Surprise History - In the last reported quarter, Eos Energy was expected to post a loss of $0.17 per share but instead reported a loss of $1.05, resulting in a surprise of -517.65% [13] - The company has not been able to beat consensus EPS estimates in any of the last four quarters, indicating a consistent trend of underperformance [14] Bottom Line - Eos Energy does not appear to be a compelling candidate for an earnings beat, and investors should consider other factors when making decisions regarding this stock ahead of its earnings release [17]
NewAmsterdam Pharma Company N.V. (NAMS) Expected to Beat Earnings Estimates: Should You Buy?
ZACKS· 2025-10-29 15:07
Core Insights - Wall Street anticipates a year-over-year decline in earnings for NewAmsterdam Pharma Company N.V. (NAMS) due to lower revenues, with a consensus expectation of a quarterly loss of $0.38 per share, reflecting a -111.1% change from the previous year [1][3] - Revenues are projected to be $3.88 million, which is an 86.7% decrease compared to the same quarter last year [3] - The stock's price movement will largely depend on how actual results compare to these estimates, with a potential for upward movement if results exceed expectations [2] Earnings Estimates and Revisions - The consensus EPS estimate has been revised down by 6.95% over the last 30 days, indicating a reassessment by analysts [4] - The Most Accurate Estimate for NewAmsterdam Pharma is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +19.13%, suggesting a likelihood of beating the consensus EPS estimate [12] Earnings Surprise History - In the last reported quarter, NewAmsterdam Pharma was expected to post a loss of $0.52 per share but actually reported a loss of -$0.15, resulting in a positive surprise of +71.15% [13] - Over the past four quarters, the company has beaten consensus EPS estimates two times [14] Industry Context - In the Zacks Medical - Drugs industry, Corcept Therapeutics is expected to report earnings of $0.18 per share, indicating a year-over-year decline of -56.1%, with revenues expected to be $219.18 million, up 20.1% from the previous year [19] - Corcept's consensus EPS estimate has been revised down by 9.7% over the last 30 days, and it has a negative Earnings ESP of -72.60%, combined with a Zacks Rank of 5 (Strong Sell), making it challenging to predict an earnings beat [20]